Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

Market Cap	3.32B +14.7%
Revenue (ttm)	827.75M +10.8%
Net Income	193.61M -9.4%
EPS	0.61 -6.0%
Shares Out	317.69M
PE Ratio	17.12
Forward PE	n/a
Dividend	0.30 (2.86%)
Ex-Dividend Date	Jun 18, 2025

Volume	1,550,500
Open	10.35
Previous Close	10.45
Day's Range	10.20 - 10.45
52-Week Range	8.77 - 16.97
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHA:603811

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1966
• Employees: 604
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603811

Financial Performance

In 2025, SHA:603811's revenue was 812.35 million, an increase of 13.72% compared to the previous year's 714.37 million. Earnings were 195.12 million, a decrease of -2.78%.